Ultrasonographic evaluation of the size of the adrenal glands of 24 diseased cats without endocrinopathies.

The ultrasonographic measurements of the adrenal glands of 24 diseased cats without a clinically or laboratory identifiable endocrinopathy were evaluated retrospectively. The mean (sd) thickness of the left adrenal glands was 3.8 (0.8) mm and their mean length was 11.3 (2.8) mm; the thickness of the right glands was 4.5 (1.0) mm and their length was 9.8 (2.4) mm. The products of thickness and length were 43.9 (20.2) mm(2) for the left gland and 45.7 (19.7) mm(2) for the right gland. There were no significant correlations between the bodyweight, body surface area or body condition scores of the cats and the thickness, length or the product of thickness and length of either gland.

Embryonic morphology and rate of implantation of human embryos following co-culture on bovine oviductal epithelial cells.

A study was undertaken to evaluate embryonic development and establish pregnancies with human embryos after in-vitro culture in two different systems. Treatment A consisted of culturing zygotes in serum-supplemented human tubal fluid culture medium (HTF). Treatment B consisted of culturing zygotes on a monolayer of bovine oviductal epithelial cells with HTF. At the time of embryo replacement, embryos in treatment B had 4.11 blastomeres present, which was greater (P < 0.05) than the 3.81 present for embryos in treatment A. In addition, the cellular fragmentation rate for treatment A embryos was 1.10, which was greater (P < 0.05) than the fragmentation rate of 0.38 for embryos within treatment B. The incidence of ongoing pregnancy was higher after replacement of co-cultured embryos (treatment B) (43%) than replacement of conventionally cultured embryos (treatment A) (29%). The implantation rate per embryo increased (P < 0.05) from 11.5 to 18.4% after co-culture. In treatment B the proportion of 'spare' embryos developing to expanded blastocysts was 58.5%, which was greater (P < 0.05) than the blastocyst development rate of 29.3% observed for embryos within treatment A.